S. Hawley

发表

The contributions of normal variation and genetic background to mammalian gene expression

P. Nelson, L. Hsu, C. Pritchard, 2006, Genome Biology.

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

Lawrence D. True, Peter S. Nelson, Celestia S. Higano, 2007, Clinical & Experimental Metastasis.

Combining Results of Microarray Experiments: A Rank Aggregation Approach

S. Falcon, Ruth Etzioni, R. Deconde, 2006, Statistical applications in genetics and molecular biology.

Analyzing Patterns of Staining in Immunohistochemical Studies: Application to a Study of Prostate Cancer Recurrence

Dean Billheimer, Ruth Etzioni, Lawrence D True, 2005, Cancer Epidemiology Biomarkers & Prevention.

Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.

J. Manson, B. Karlan, C. Berg, 2015, Gynecologic oncology.

Loss of stearoyl‐CoA desaturase expression is a frequent event in prostate carcinoma

P. Nelson, Ruth Etzioni, L. True, 2005, International journal of cancer.

IGF‐I and IGFBP‐3 polymorphisms and risk of prostate cancer

Ruth Etzioni, J. Stanford, E. Ostrander, 2005, The Prostate.

The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial

N. Urban, D. Buist, S. Hawley, 2016, Cancer.

Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for “large” cribriform prostatic adenocarcinoma

M. Cooperberg, P. Carroll, J. Brooks, 2022, Modern Pathology.

PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.

P. Carroll, J. Brooks, P. Nelson, 2016, European urology focus.

A molecular correlate to the Gleason grading system for prostate adenocarcinoma.

Leroy Hood, Milton Datta, Paul Lange, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.

Daniel W Lin, Beatrice S Knudsen, P. Nelson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH

P. Carroll, J. Brooks, P. Nelson, 2016, Modern Pathology.

The androgen‐regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma

M. Matsumura, R. Vessella, L. True, 2008, The Journal of pathology.

Tumorigenesis and Neoplastic Progression Regulation of Hepatocyte Activator Inhibitor-1 Expression by Androgen and Oncogenic Transformation in the Prostate

Daniel B. Martin, S. Falcon, P. Nelson, 2005 .

809: The Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis

P. Nelson, A. Kristal, S. Hawley, 2006 .

Low-Fat, Low-Glycemic Load Diet and Gene Expression in Human Prostate Epithelium: A Feasibility Study of Using cDNA Microarrays to Assess the Response to Dietary Intervention in Target Tissues

P. Nelson, A. Kristal, J. Schenk, 2007, Cancer Epidemiology Biomarkers & Prevention.

False-Positive Screening Events and Worry Influence Decisions About Surgery Among High-Risk Women

B. Karlan, N. Urban, S. Hawley, 2019, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening

Sanjiv S Gambhir, Charles W Drescher, Nicole Urban, 2012, Cancer Prevention Research.